Cargando…
Inhibition of HIF-1α by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo
In a previous study, we showed that a novel anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106, ECyd) increased the antitumour efficacy of X-irradiation. However, its effects on hypoxic cells in tumours remain unclarified. Here, we show that TAS106 enhances the induction of apo...
Autores principales: | Yasui, H, Ogura, A, Asanuma, T, Matsuda, A, Kashiwakura, I, Kuwabara, M, Inanami, O |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579694/ https://www.ncbi.nlm.nih.gov/pubmed/18854835 http://dx.doi.org/10.1038/sj.bjc.6604720 |
Ejemplares similares
-
A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression
por: Meike, Shunsuke, et al.
Publicado: (2011) -
Cellular and Biochemical Mechanisms of the Resistance of Human Cancer Cells to a New Anticancer Ribo‐nucleoside, TAS‐106
por: Shimamoto, Yuji, et al.
Publicado: (2002) -
Sensitivity of Human Cancer Cells to the New Anticancer Ribo‐nucleoside TAS–106 Is Correlated with Expression of Uridine‐cytidine Kinase 2
por: Shimamoto, Yuji, et al.
Publicado: (2002) -
Antitumor Activity and Pharmacokinetics of TAS‐106, l‐(3‐C‐Ethynyl‐β‐D‐ribo‐pentofuranosyl)cytosine
por: Shimamoto, Yuji, et al.
Publicado: (2001) -
Regulation of Cell Survival and Death Signals Induced by Oxidative Stress
por: Kuwabara, Mikinori, et al.
Publicado: (2008)